Unique ID issued by UMIN | UMIN000009242 |
---|---|
Receipt number | R000010852 |
Scientific Title | A randomized controlled trial of internet-assisted Cognitive Behavioral Therapy for depression |
Date of disclosure of the study information | 2012/11/01 |
Last modified on | 2016/10/14 18:52:23 |
A randomized controlled trial of internet-assisted Cognitive Behavioral Therapy for depression
i-CBT Study
A randomized controlled trial of internet-assisted Cognitive Behavioral Therapy for depression
i-CBT Study
Japan |
Major Depressive Disorder
Psychiatry |
Others
NO
To assess the efficacy of the internet-assisted cognitive behavior therapy with waiting-list control group in adult patients with moderate major depression (Hamilton-Depression Scale17-items(HAMD-17)>=14) who had received adequate one antidepressant trial at least 6weeks at study entry.
Safety,Efficacy
Confirmatory
Pragmatic
Phase III
Hamilton Depression Rating Scale (HAMD-17) score at endpoint will be compared between the groups
Response rate(defined as 50% reduction of baseline HAMD-17),remission rate(defined as HAMD=<7),subjective depression(measured with the BDI and QIDS),quality of life(measured with EQ-5D and SF-36) and vulnerability measure of depression and cognition (DAS) at 12week and post-intervention phase(up to 6months) will be compared between the groups.Cost effectiveness (ICER per remitted patient and ICER per QALY) will be also compared between the groups.
Interventional
Parallel
Randomized
Individual
Single blind -investigator(s) and assessor(s) are blinded
Active
YES
YES
Institution is considered as adjustment factor in dynamic allocation.
NO
Central registration
2
Treatment
Behavior,custom |
internet-assisted cognitive behavior therapy in addition to treatment as usual
treatment as usual
20 | years-old | <= |
65 | years-old | > |
Male and Female
1.Subjects with current DSM-IV Major Depressive Disorder based on SCID at screening.
2.Subjects with HAMD-17 score>=14 at screening.
3.Subjects who had received at least adequate one trial of antidepressant therapy for more than 6weeks.
4.Aged 20 years or older, and younger than 65 years at screening.
5.Subjects who give full consent in the participation of the study.
6.Subjects who can be used to use the internet.
7.Subjects who have the possibility that they can go to the hospital more than 6 times during the study period.
1.No alcohol or substance use disorder in 6 months prior to the screening.
2.No history or concurrent manic or psychotic episode.
3.No other primary DSM-IV Axis I Disorders at screening.
4.No comorbid of antisocial personality disorder.
5.No serious suicidal ideation at screening.
6.No past treatment of individual CBT.
7.No organic brain lesions or major cognitive deficits in a year prior to the screening.
8.No severe or unstable medical co-morbidities at screening.
9.Other relevant reason decided by the i-CBT principal investigator.
40
1st name | |
Middle name | |
Last name | Atsuo Nakagawa, MD, PhD |
National Center of Neurology & Psychiatry
Translational Medical Center/CBT Center
Ogawahigashi-cho 4-1-1, Kodaira-shi Tokyo 187-8551, Japan
042-341-2711
anakagawa@ncnp.go.jp
1st name | |
Middle name | |
Last name | Yoshiyo Oguchi |
National Center of Neurology & Psychiatry
CBT Center
Ogawahigashi-cho 4-1-1, Kodaira-shi Tokyo 187-8551, Japan
042-341-2711
yoguchi1978@gmail.com
i-CBT study group
National Center of Neurology and Psychiatry Intramural Grant Aid
Other
Japan
NO
慶應義塾大学医学部(東京都)
独立行政法人国立病院機構東京医療センター(東京都)
桜ヶ丘記念病院(東京都)
2012 | Year | 11 | Month | 01 | Day |
Unpublished
Completed
2012 | Year | 06 | Month | 25 | Day |
2012 | Year | 11 | Month | 08 | Day |
2016 | Year | 05 | Month | 25 | Day |
2016 | Year | 05 | Month | 25 | Day |
2016 | Year | 10 | Month | 14 | Day |
2016 | Year | 11 | Month | 15 | Day |
2012 | Year | 11 | Month | 01 | Day |
2016 | Year | 10 | Month | 14 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010852